Publication: Update on early mortality syndrome/acute hepatopancreatic necrosis disease by April 2018
Issued Date
2019-02-01
Resource Type
ISSN
17497345
08938849
08938849
Other identifier(s)
2-s2.0-85052932313
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the World Aquaculture Society. Vol.50, No.1 (2019), 5-17
Suggested Citation
Anuphap Prachumwat, Suparat Taengchaiyaphum, Natthinee Mungkongwongsiri, Diva J. Aldama-Cano, Timothy W. Flegel, Kallaya Sritunyalucksana Update on early mortality syndrome/acute hepatopancreatic necrosis disease by April 2018. Journal of the World Aquaculture Society. Vol.50, No.1 (2019), 5-17. doi:10.1111/jwas.12559 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/49820
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Update on early mortality syndrome/acute hepatopancreatic necrosis disease by April 2018
Abstract
© Copyright by the World Aquaculture Society 2018 Outbreaks of acute hepatopancreatic necrosis disease (AHPND) have caused great economic losses to many shrimp-producing countries in Asia since its first appearance in 2009. The causative agent was reported in 2013 as specific isolates of Vibrio parahaemolyticus (VP AHPND ) that were later found to harbor a plasmid (pVA) encoding the Pir-like binary toxin genes Pir vp A and Pir vp B. VP AHPND isolates colonize the shrimp stomach and release the binary toxins that cause massive sloughing of tubule epithelial cells followed by shrimp mortality. More recent information indicates that pVA plasmid and variants occur in many V. parahaemolyticus serotypes and also in other Vibrio species such as Vibrio campbellii, Vibrio harveyi, and Vibrio owensii. Information on such genomic and proteomic studies of different VP AHPND isolates from different countries are reviewed. A cohort study carried out in Thailand in 2014 indicated that AHPND outbreaks account for only a portion of the disease outbreaks reported by shrimp farmers as outbreaks of early mortality syndrome (EMS). It is recommended that a regional research network and surveillance program for newly emerging or re-emerging pathogens be established to speed up the process of diagnosis and the implementation of coordinated control measures and to avoid a repeat of the EMS/AHPND scenario.
